Cultivated Meat and Animal Welfare: Promise and Challenges

Cultivated meat - grown from animal cells without slaughter - has potential to dramatically reduce farm animal suffering, but faces technical, regulatory, and scaling challenges.

Key Facts

Cultivated meat is produced by taking cells from an animal biopsy and growing them in a bioreactor
Singapore became the first country to approve cultivated chicken for sale in 2020
The US FDA and USDA jointly approved cultivated chicken products in 2023
Current cultivated meat production costs have fallen dramatically but remain above conventional meat prices
Fetal bovine serum has historically been used as a growth medium, raising welfare concerns being addressed by serum-free alternatives
Cultivated meat could reduce land use by 99% and greenhouse gas emissions by 78-96% compared to conventional beef

Welfare Considerations

If cultivated meat reaches cost parity with conventional meat, it could eliminate the need to raise and slaughter billions of land animals annually. This represents potentially the largest single reduction in animal suffering in human history. The welfare case is compelling, though transition challenges including industry displacement, regulatory approval, and consumer acceptance must be navigated. The current welfare cost is a small number of cell donor biopsies rather than billions of slaughtered animals.

What You Can Do

Support research funding for cultivated meat and other alternative protein technologies
Advocate for streamlined regulatory pathways for cultivated meat approval in your country
Back Good Food Institute and equivalent organizations advancing alternative protein development
Try cultivated or plant-based protein products to help build the market
Engage positively with alternative protein innovation as a welfare-aligned food system transformation